Catherine G. Haase

Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours

Ahmad Awada, Alain Hendlisz, Thierry Gil et al. · British Journal of Cancer · 2005 · 338 citations · Full text

The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls

Catherine G. Haase, Johannes Guggenmos, Uschi Brehm et al. · Journal of Neuroimmunology · 2001 · 116 citations

Neurodegenerative Diseases, Normal Healthy Controls, Autoimmune Disease +10

Energetics of stress: linking plasma cortisol levels to metabolic rate in mammals

Catherine G. Haase, Andrea K. Long, James F. Gillooly · Biology Letters · 2016 · 112 citations · Full text

Metabolic Rate, Fitness, Mammalian Physiology +17

Short-Term Cognitive Training Improves Mental Efficiency and Mood in Patients with Multiple Sclerosis

Andrzej Brenk, K. Laun, Catherine G. Haase · European Neurology · 2008 · 56 citations

Results of a phase I trial of BAY 43-9006 in combination with doxorubicin in patients with primary hepatic cancer

Heike Richly, P. Kupsch, K. J. Passage et al. · International Journal of Clinical Pharmacology and Therapeutics · 2004 · 51 citations

Hepatology, Medicine, Liver Physiology +8